Squamous Cell Carcinoma of the Bronchus

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-11-24
Clinical Trial Update: Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy [Phase 2]
Phase 2 trial evaluating gefitinib for squamous cell carcinoma of the bronchus after failure of first-line chemotherapy; study completed.